FRESENIUS MEDICAL CARE RENAL SERVICES LIMITED
Get an alert when FRESENIUS MEDICAL CARE RENAL SERVICES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£2k
Latest balance sheet
Net assets
£16m
-28.6% vs 2024
Employees
157
-16.5% vs 2024
Profit before tax
-£3.3m
-236.1% lowest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £45,202,000 | £50,708,000 | £56,475,000 | +11.4% | |
| Operating profit | £1,888,000 | £2,900,000 | -£2,360,000 | -181.4% | |
| Profit before tax | £1,795,000 | £2,399,000 | -£3,264,000 | -236.1% | |
| Net profit | £2,420,000 | £3,213,000 | -£6,285,000 | -295.6% | |
| Cash | — | — | £2,000 | — | |
| Total assets less current liabilities | — | £32,050,000 | £30,613,000 | -4.5% | |
| Net assets | — | £21,942,000 | £15,657,000 | -28.6% | |
| Equity | — | £21,942,000 | £15,657,000 | -28.6% | |
| Average employees | — | 188 | 157 | -16.5% | |
| Wages | — | £8,963,000 | £10,271,000 | +14.6% | |
| Directors' remuneration | — | £136,000 | £281,000 | +106.6% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 4.2% | 5.7% | -4.2% | |
| Net margin | 5.4% | 6.3% | -11.1% | |
| Return on capital employed | — | 9.0% | -7.7% | |
| Gearing (liabilities / total assets) | — | 71.0% | 78.0% | |
| Current ratio | — | 1.09x | 0.97x | |
| Interest cover | 11.80x | 3.81x | -2.52x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- FRESENIUS MEDICAL CARE RENAL SERVICES LIMITED 1999-03-12 → present
- U.K. RENAL SERVICES LIMITED 1993-01-07 → 1999-03-12
- ALNERY NO. 1244 LIMITED 1992-11-26 → 1993-01-07
Audit & accounting basis
- Accounting basis
- FRS 102
- Auditor
- Cooper Parry Group Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the balance sheet date, the company had net current liabilities of £1,186,000 (2024: net current asset of £4,001,000, as restated), with cash made available through a group cash pooling arrangement. At the time of signing these accounts, the directors have considered the going concern position, and are satisfied that the company will continue to trade for a period of at least 12 months from the date of signing these accounts. On that basis, the directors have prepared these financial statements on a going concern basis.”
Significant events
- “During the year turnover increased by 11.4% (2024: 12.2%) due to opening new clinics during the year, full year impact from clinics opened in 2025 and organic patient growth, however the company made an operating loss of £2,360,000 during the year due to the transfer of clinical manager salaries for disclosure from another group entity, to align with other non-nursing staff costs across the group.”
- “JE Lawrence was appointed as a director on 2 June 2025.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 23 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BELL, Laura | Director | 2017-10-17 | Mar 1982 | British |
| LAWRENCE, Jonathon Edward, Mr. | Director | 2025-06-02 | Jan 1971 | British |
| SINGH WILLIAMS, Anita | Director | 2023-07-17 | Feb 1968 | British |
| SLATER, Christopher James | Director | 2023-07-17 | Jan 1982 | British |
Show 23 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| KINREAD, Jonathan | Secretary | 1996-06-25 | 1996-08-15 |
| MAHONEY, Steve Alexander | Secretary | 2001-10-31 | 2015-11-28 |
| MILLER, Christopher Hugh | Secretary | 1997-10-21 | 2001-03-07 |
| WHITFIELD, Frank Davison | Secretary | 1996-08-15 | 1997-11-21 |
| WHITTING IV, John Kimball | Secretary | 1992-12-22 | 1995-07-01 |
| YARROW, Nicholas John | Secretary | 1995-07-01 | 1996-06-25 |
| ALNERY INCORPORATIONS NO 1 LIMITED | Corporate Nominee Secretary | 1992-11-26 | 1992-12-22 |
| WILLOUGHBY CORPORATE SECRETARIAL LIMITED | Corporate Secretary | 2001-03-12 | 2001-10-31 |
| FORD, Christopher Thomas | Director | 1992-12-22 | 1997-12-31 |
| GIJSBERS, Helena Lambertina Edmunda Maria | Director | 2017-10-17 | 2023-07-12 |
| HAMPERS, Constantine L | Director | 1992-12-22 | 1996-08-15 |
| HOUGHTON, Christine | Director | 1997-01-09 | 2012-08-31 |
| KINREAD, Jonathan | Director | 1993-07-01 | 1997-03-31 |
| MARCELLI, Daniele, Doctor | Director | 2003-01-23 | 2017-10-17 |
| MAZZEI, Antony | Director | 2020-06-05 | 2024-12-10 |
| O'BRIEN, Peter Martin | Director | 1999-12-01 | 2015-08-14 |
| ORLANDINI, Giancarlo | Director | 1999-03-04 | 2002-12-01 |
| RICHARDS, Nicholas Talbot, Dr | Director | 2004-07-05 | 2014-12-19 |
| WHEELDON, Timothy Scott | Director | 2015-11-16 | 2023-07-12 |
| WILLETTS, Susan | Director | 2010-11-01 | 2018-06-01 |
| WILSON, Duncan James | Director | 2012-08-28 | 2016-12-15 |
| ALNERY INCORPORATIONS NO 1 LIMITED | Corporate Nominee Director | 1992-11-26 | 1992-12-22 |
| ALNERY INCORPORATIONS NO 2 LIMITED | Corporate Nominee Director | 1992-11-26 | 1992-12-22 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Fresenius Medical Care (Holdings) Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 145 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-14 | AA | accounts | Accounts with accounts type full | |
| 2026-03-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-12 | AA | accounts | Accounts with accounts type full | |
| 2025-06-13 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-13 | CH01 | officers | Change person director company with change date | |
| 2025-02-12 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-07 | AA | accounts | Accounts with accounts type full | |
| 2024-04-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-05 | AA | accounts | Accounts with accounts type full | |
| 2023-07-21 | CH01 | officers | Change person director company with change date | |
| 2023-07-20 | CH01 | officers | Change person director company with change date | |
| 2023-07-18 | AP01 | officers | Appoint person director company with name date | |
| 2023-07-17 | AP01 | officers | Appoint person director company with name date | |
| 2023-07-17 | TM01 | officers | Termination director company with name termination date | |
| 2023-07-17 | TM01 | officers | Termination director company with name termination date | |
| 2023-05-22 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-03-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-05 | AA | accounts | Accounts with accounts type full | |
| 2022-03-21 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.